遗传性代谢疾病的临床和生化特征。VII. 眼部表型。
Clinical and biochemical footprints of inherited metabolic disorders. VII. Ocular phenotypes.
机构信息
Department of Pediatrics, Amalia Children's Hospital Radboud Center for Mitochondrial and Metabolic Diseases, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
出版信息
Mol Genet Metab. 2022 Apr;135(4):311-319. doi: 10.1016/j.ymgme.2022.02.002. Epub 2022 Feb 15.
Abstract
Ocular manifestations are observed in approximately one third of all inherited metabolic disorders (IMDs). Although ocular involvement is not life-threatening, it can result in severe vision loss, thereby leading to an additional burden for the patient. Retinal degeneration with or without optic atrophy is the most frequent phenotype, followed by oculomotor problems, involvement of the cornea and lens, and refractive errors. These phenotypes can provide valuable clues that contribute to its diagnosis. In this issue we found 577 relevant IMDs leading to ophthalmologic manifestations. This article is the seventh of a series attempting to create and maintain a comprehensive list of clinical and metabolic differential diagnoses according to system involvement.
摘要
约三分之一的遗传性代谢疾病（IMD）患者会出现眼部表现。虽然眼部受累不会危及生命，但可能导致严重的视力丧失，从而给患者带来额外的负担。最常见的表型是视网膜变性伴或不伴视神经萎缩，其次是眼球运动问题、角膜和晶状体受累以及屈光不正。这些表型可以提供有价值的线索，有助于诊断。在本期中，我们发现了 577 种与眼部表现相关的 IMD。本文是根据系统受累情况，尝试创建和维护临床和代谢鉴别诊断综合列表的系列文章中的第 7 篇。
相似文献
1
Clinical and biochemical footprints of inherited metabolic disorders. VII. Ocular phenotypes.遗传性代谢疾病的临床和生化特征。VII. 眼部表型。
Mol Genet Metab. 2022 Apr;135(4):311-319. doi: 10.1016/j.ymgme.2022.02.002. Epub 2022 Feb 15.
2
Clinical and biochemical footprints of inherited metabolic diseases. XIV. Metabolic kidney diseases.遗传性代谢疾病的临床与生化特征。十四、代谢性肾脏疾病。
Mol Genet Metab. 2023 Nov;140(3):107683. doi: 10.1016/j.ymgme.2023.107683. Epub 2023 Aug 12.
3
Clinical and biochemical footprints of inherited metabolic diseases: Ia. Movement disorders, updated.遗传性代谢疾病的临床和生化特征：Ia. 运动障碍，更新版
Mol Genet Metab. 2025 May;145(1):109084. doi: 10.1016/j.ymgme.2025.109084. Epub 2025 Mar 18.
4
Clinical and biochemical footprints of inherited metabolic diseases. IV. Metabolic cardiovascular disease.遗传性代谢疾病的临床和生化特征。四、代谢性心血管疾病。
Mol Genet Metab. 2021 Feb;132(2):112-118. doi: 10.1016/j.ymgme.2020.12.290. Epub 2020 Dec 25.
5
Clinical and biochemical footprints of inherited metabolic disease. V. Cerebral palsy phenotypes.遗传性代谢病的临床和生化特征。五、脑瘫表型。
Mol Genet Metab. 2022 Dec;137(4):445-448. doi: 10.1016/j.ymgme.2021.03.008. Epub 2021 Mar 13.
6
Spectrum of ocular manifestations in cobalamin C and cobalamin A types of methylmalonic acidemia.钴胺素C型和钴胺素A型甲基丙二酸血症的眼部表现谱
Ophthalmic Genet. 2016 Dec;37(4):404-414. doi: 10.3109/13816810.2015.1121500. Epub 2016 Mar 15.
7
Clinical and biochemical footprints of inherited metabolic disorders. XI. Gastrointestinal symptoms.遗传代谢疾病的临床和生化特征。十一、胃肠道症状。
Mol Genet Metab. 2023 Mar;138(3):107528. doi: 10.1016/j.ymgme.2023.107528. Epub 2023 Feb 1.
8
Clinical and biochemical footprints of inherited metabolic diseases. XII. Immunological defects.遗传性代谢疾病的临床和生化特征。十二、免疫缺陷。
Mol Genet Metab. 2023 May;139(1):107582. doi: 10.1016/j.ymgme.2023.107582. Epub 2023 Apr 17.
9
Clinical and biochemical footprints of inherited metabolic diseases. IX. Metabolic ear disease.遗传性代谢疾病的临床和生化特征。IX. 代谢性耳病。
Mol Genet Metab. 2022 Nov;137(3):223-229. doi: 10.1016/j.ymgme.2022.09.005. Epub 2022 Sep 23.
10
Clinical and biochemical footprints of inherited metabolic disease. XVI. Hematological abnormalities.遗传性代谢疾病的临床与生化特征。十六、血液学异常。
Mol Genet Metab. 2023 Dec;140(4):107735. doi: 10.1016/j.ymgme.2023.107735. Epub 2023 Nov 13.
引用本文的文献
1
Clinical and biochemical footprints of inherited metabolic disease. XVI. Hematological abnormalities.遗传性代谢疾病的临床与生化特征。十六、血液学异常。
Mol Genet Metab. 2023 Dec;140(4):107735. doi: 10.1016/j.ymgme.2023.107735. Epub 2023 Nov 13.
2
Clinical and biochemical footprints of inherited metabolic diseases. XIV. Metabolic kidney diseases.遗传性代谢疾病的临床与生化特征。十四、代谢性肾脏疾病。
Mol Genet Metab. 2023 Nov;140(3):107683. doi: 10.1016/j.ymgme.2023.107683. Epub 2023 Aug 12.
3
Clinical and biochemical footprints of inherited metabolic diseases. XIII. Respiratory manifestations.遗传性代谢疾病的临床和生化特征。十三、呼吸表现。
Mol Genet Metab. 2023 Nov;140(3):107655. doi: 10.1016/j.ymgme.2023.107655. Epub 2023 Jul 24.
4
Clinical and biochemical footprints of inherited metabolic diseases. XII. Immunological defects.遗传性代谢疾病的临床和生化特征。十二、免疫缺陷。
Mol Genet Metab. 2023 May;139(1):107582. doi: 10.1016/j.ymgme.2023.107582. Epub 2023 Apr 17.
5
Clinical and biochemical footprints of inherited metabolic disorders. XI. Gastrointestinal symptoms.遗传代谢疾病的临床和生化特征。十一、胃肠道症状。
Mol Genet Metab. 2023 Mar;138(3):107528. doi: 10.1016/j.ymgme.2023.107528. Epub 2023 Feb 1.
6
Clinical and biochemical footprints of inherited metabolic diseases. IX. Metabolic ear disease.遗传性代谢疾病的临床和生化特征。IX. 代谢性耳病。
Mol Genet Metab. 2022 Nov;137(3):223-229. doi: 10.1016/j.ymgme.2022.09.005. Epub 2022 Sep 23.
7
Clinical and biochemical footprints of inherited metabolic disorders: X. Metabolic myopathies.遗传代谢性疾病的临床和生化特征：X. 代谢性肌病。
Mol Genet Metab. 2022 Sep-Oct;137(1-2):213-222. doi: 10.1016/j.ymgme.2022.09.004. Epub 2022 Sep 18.
8
Clinical and biochemical footprints of inherited metabolic diseases. VIII. Neoplasias.遗传代谢性疾病的临床和生化特征。VIII. 肿瘤。
Mol Genet Metab. 2022 Jun;136(2):118-124. doi: 10.1016/j.ymgme.2022.03.011. Epub 2022 Mar 28.
本文引用的文献
1
Congenital cataract: a guide to genetic and clinical management.先天性白内障：遗传与临床管理指南
Ther Adv Rare Dis. 2020 Jul 22;1:2633004020938061. doi: 10.1177/2633004020938061. eCollection 2020 Jan-Dec.
2
A review of treatment modalities in gyrate atrophy of the choroid and retina (GACR).脉络膜和视网膜脑回样萎缩（GACR）治疗方法的综述。
Mol Genet Metab. 2021 Sep-Oct;134(1-2):96-116. doi: 10.1016/j.ymgme.2021.07.010. Epub 2021 Jul 26.
3
Clinical and biochemical footprints of inherited metabolic diseases. VI. Metabolic dermatoses.遗传性代谢病的临床和生化特征。六、代谢性皮肤病。
Mol Genet Metab. 2021 Sep-Oct;134(1-2):87-95. doi: 10.1016/j.ymgme.2021.07.005. Epub 2021 Jul 21.
4
CERKL, a retinal dystrophy gene, regulates mitochondrial function and dynamics in the mammalian retina.CERKL 是一种视网膜变性基因，可调节哺乳动物视网膜中的线粒体功能和动态。
Neurobiol Dis. 2021 Aug;156:105405. doi: 10.1016/j.nbd.2021.105405. Epub 2021 May 25.
5
Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app.可治疗的遗传性代谢障碍导致的智力障碍：2021 年回顾和数字应用程序。
Orphanet J Rare Dis. 2021 Apr 12;16(1):170. doi: 10.1186/s13023-021-01727-2.
6
Clinical and biochemical footprints of inherited metabolic disease. V. Cerebral palsy phenotypes.遗传性代谢病的临床和生化特征。五、脑瘫表型。
Mol Genet Metab. 2022 Dec;137(4):445-448. doi: 10.1016/j.ymgme.2021.03.008. Epub 2021 Mar 13.
7
Eye involvement in inherited metabolic disorders.遗传性代谢疾病中的眼部受累情况。
Ther Adv Ophthalmol. 2020 Dec 29;12:2515841420979109. doi: 10.1177/2515841420979109. eCollection 2020 Jan-Dec.
8
Clinical and biochemical footprints of inherited metabolic diseases. IV. Metabolic cardiovascular disease.遗传性代谢疾病的临床和生化特征。四、代谢性心血管疾病。
Mol Genet Metab. 2021 Feb;132(2):112-118. doi: 10.1016/j.ymgme.2020.12.290. Epub 2020 Dec 25.
9
An international classification of inherited metabolic disorders (ICIMD).国际遗传性代谢疾病分类（ICIMD）。
J Inherit Metab Dis. 2021 Jan;44(1):164-177. doi: 10.1002/jimd.12348.
10
The role of clinical response to treatment in determining pathogenicity of genomic variants.治疗临床应答在确定基因组变异致病性中的作用。
Genet Med. 2021 Mar;23(3):581-585. doi: 10.1038/s41436-020-00996-9. Epub 2020 Oct 22.
Zotero 插件